Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

about

A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering

P2860

Q56888917-8F4A1268-7C72-450B-B814-BECBF0EF2A06

P2860

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q49599316

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@en

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@nl

type

Item

label

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@en

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@nl

prefLabel

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@en

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@nl

P1476

Assessment of kallikrein 6 as ...... arker for Alzheimer's disease.

@en

P2093

Antoninus Soosaipillai

http://www.w3.org/2001/XMLSchema#string

Camilla Lauridsen

http://www.w3.org/2001/XMLSchema#string

Guro Berge

http://www.w3.org/2001/XMLSchema#string

Gøril Rolfseng Grøntvedt

http://www.w3.org/2001/XMLSchema#string

Ilijana Begcevic

http://www.w3.org/2001/XMLSchema#string

Ina Møller

http://www.w3.org/2001/XMLSchema#string

Kalicharan Patra

http://www.w3.org/2001/XMLSchema#string

Linda R White

http://www.w3.org/2001/XMLSchema#string

Sigrid Botne Sando

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients

Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease

Cloning and characterization of novel isoforms of the human kallikrein 6 gene

Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease

Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain

P2888

s13195-018-0336-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13195-018-0336-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Oskar Hansson

Eleftherios P. Diamandis

P577

2018-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100692385

http://www.w3.org/2001/XMLSchema#string

P698

29378650

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5789599

http://www.w3.org/2001/XMLSchema#string

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

about

P2860

P2860

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932